AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
TRISOMY-12 AND LYMPHOPLASMACYTOID LYMPHOCYTES IN CHRONIC LEUKEMIC B-CELL DISORDERS
Authors: HJALMAR V KIMBY E MATUTES E SUNDSTROM C JACOBSSON B ARVIDSSON I HAST R
Citation: V. Hjalmar et al., TRISOMY-12 AND LYMPHOPLASMACYTOID LYMPHOCYTES IN CHRONIC LEUKEMIC B-CELL DISORDERS, Haematologica, 83(7), 1998, pp. 602-609
FISH IN COMBINATION WITH MORPHOLOGY (MGG FISH) INCREASES THE SENSITIVITY TO DETECT MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA/
Authors: HAST R BERNELL P ARVIDSSON I JAKOBSSON B
Citation: R. Hast et al., FISH IN COMBINATION WITH MORPHOLOGY (MGG FISH) INCREASES THE SENSITIVITY TO DETECT MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 98-98
DETECTION OF MASKED MONOSOMY-7 IN MYELODYSPLASTIC SYNDROMES BY FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: JAKOVLEVA K OGARD I ARVIDSSON I SHAN L JACOBSSON B SWOLIN B HAST R
Citation: K. Jakovleva et al., DETECTION OF MASKED MONOSOMY-7 IN MYELODYSPLASTIC SYNDROMES BY FLUORESCENCE IN-SITU HYBRIDIZATION, British Journal of Haematology, 102(1), 1998, pp. 338-338
GAIN OF CHROMOSOME-7 MARKS THE PROGRESSION FROM INDOLENT TO AGGRESSIVE FOLLICLE CENTER LYMPHOMA AND IS A COMMON FINDING IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA - A STUDY BY FISH
Authors: BERNELL P JACOBSSON B LILIEMARK J HJALMAR V ARVIDSSON I HAST R
Citation: P. Bernell et al., GAIN OF CHROMOSOME-7 MARKS THE PROGRESSION FROM INDOLENT TO AGGRESSIVE FOLLICLE CENTER LYMPHOMA AND IS A COMMON FINDING IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA - A STUDY BY FISH, British Journal of Haematology, 101(3), 1998, pp. 487-491
PLASMA PHARMACOKINETICS OF IDARUBICIN AND ITS 13-DIHYDRO METABOLITE -A COMPARISON OF BOLUS VERSUS 2 H INFUSION DURING A 3 DAY COURSE
Authors: EKSBORG S BJORKHOLM M HAST R FAGERLUND E
Citation: S. Eksborg et al., PLASMA PHARMACOKINETICS OF IDARUBICIN AND ITS 13-DIHYDRO METABOLITE -A COMPARISON OF BOLUS VERSUS 2 H INFUSION DURING A 3 DAY COURSE, Anti-cancer drugs, 8(1), 1997, pp. 42-47
DIFFERENCES IN CELL LINEAGE INVOLVEMENT BETWEEN MDS-AML AND DE-NOVO AML STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN COMBINATION WITH MORPHOLOGY
Authors: BERNELL P ARVIDSSON I HAST R JACOBSSON B STENKE L
Citation: P. Bernell et al., DIFFERENCES IN CELL LINEAGE INVOLVEMENT BETWEEN MDS-AML AND DE-NOVO AML STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN COMBINATION WITH MORPHOLOGY, European journal of haematology, 58(4), 1997, pp. 241-245
TRISOMY-12 AND LYMPHOPLASMACYTOID LYMPHOMAS
Authors: HJALMAR V JACOBSSON B ARVIDSSON I HAST R KIMBY E
Citation: V. Hjalmar et al., TRISOMY-12 AND LYMPHOPLASMACYTOID LYMPHOMAS, Blood, 90(10), 1997, pp. 3901-3901
GAIN OF CHROMOSOME-7 IN FOLLICLE CENTER AND DIFFUSE LARGE B-CELL LYMPHOMAS - A STUDY USING FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: JACOBSSON B BERNELL P ARVIDSSON I HAST R
Citation: B. Jacobsson et al., GAIN OF CHROMOSOME-7 IN FOLLICLE CENTER AND DIFFUSE LARGE B-CELL LYMPHOMAS - A STUDY USING FLUORESCENCE IN-SITU HYBRIDIZATION, Blood, 90(10), 1997, pp. 3905-3905
LONG-TERM FOLLOW-UP OF 18 MDS PATIENTS RESPONDING TO RHEPO TREATMENT
Authors: HAST R WALLVIK J STENKE L BERNELL P ERIKSSON M
Citation: R. Hast et al., LONG-TERM FOLLOW-UP OF 18 MDS PATIENTS RESPONDING TO RHEPO TREATMENT, Blood, 90(10), 1997, pp. 365-365
IMIPENEM CILASTATIN MONOTHERAPY AS SALVAGE TREATMENT IN FEBRILE NEUTROPENIC PATIENTS/
Authors: ENGERVALL P GUNTHER G LJUNGMAN P LONNQVIST B HAST R STIERNSTEDT G KALIN M RINGERTZ S BJORKHOLM M
Citation: P. Engervall et al., IMIPENEM CILASTATIN MONOTHERAPY AS SALVAGE TREATMENT IN FEBRILE NEUTROPENIC PATIENTS/, Journal of chemotherapy, 8(5), 1996, pp. 382-386
CLONAL CELL LINEAGE INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZAIION AND MORPHOLOGY
Authors: BERNELL P JACOBSSON B NORDGREN A HAST R
Citation: P. Bernell et al., CLONAL CELL LINEAGE INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES STUDIED BY FLUORESCENCE IN-SITU HYBRIDIZAIION AND MORPHOLOGY, Leukemia, 10(4), 1996, pp. 662-668
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G BJOREMAN M BJORKHOLM M CARNESKOG J GAHRTON G HAST R KARL H LANNGNIELSEN J LOFVENBERG E MALM C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Bone marrow transplantation, 17, 1996, pp. 63-64
A SEQUENTIAL ERYTHROPOIETIN AND GM-CSF SCHEDULE OFFERS CLINICAL BENEFITS IN THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES
Authors: BERNELL P STENKE L WALLVIK J HIPPE E HAST R
Citation: P. Bernell et al., A SEQUENTIAL ERYTHROPOIETIN AND GM-CSF SCHEDULE OFFERS CLINICAL BENEFITS IN THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES, Leukemia research, 20(8), 1996, pp. 693-699
TRIMETHOPRIM-SULFAMETHOXAZOLE PLUS AMIKACIN VERSUS CEFTAZIDIME MONOTHERAPY AS EMPIRICAL-TREATMENT IN PATIENTS WITH NEUTROPENIA AND FEVER
Authors: ENGERVALL P GUNTHER G LJUNGMAN P LONNQVIST B HAST R STIERNSTEDT G KALIN M RINGERTZ S BJOKHOLM M
Citation: P. Engervall et al., TRIMETHOPRIM-SULFAMETHOXAZOLE PLUS AMIKACIN VERSUS CEFTAZIDIME MONOTHERAPY AS EMPIRICAL-TREATMENT IN PATIENTS WITH NEUTROPENIA AND FEVER, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 297-303
CLASSICAL MORPHOLOGY, ESTERASE CYTOCHEMISTRY, AND INTERPHASE CYTOGENETICS OF PERIPHERAL-BLOOD AND BONE-MARROW SMEARS
Authors: JACOBSSON B BERNELL P ARVIDSSON I HAST R
Citation: B. Jacobsson et al., CLASSICAL MORPHOLOGY, ESTERASE CYTOCHEMISTRY, AND INTERPHASE CYTOGENETICS OF PERIPHERAL-BLOOD AND BONE-MARROW SMEARS, The Journal of histochemistry and cytochemistry, 44(11), 1996, pp. 1303-1309
FLUORESCENCE IN-SITU HYBRIDIZATION IN COMBINATION WITH MORPHOLOGY DETECTS MINIMAL RESIDUAL DISEASE IN REMISSION AND HERALDS RELAPSE IN ACUTE-LEUKEMIA
Authors: BERNELL P ARVIDSSON I JACOBSSON B HAST R
Citation: P. Bernell et al., FLUORESCENCE IN-SITU HYBRIDIZATION IN COMBINATION WITH MORPHOLOGY DETECTS MINIMAL RESIDUAL DISEASE IN REMISSION AND HERALDS RELAPSE IN ACUTE-LEUKEMIA, British Journal of Haematology, 95(4), 1996, pp. 666-672
INTERPHASE CYTOGENETICS BY FISH MORPHOLOGY IN MYELODYSPLASTIC SYNDROMES - A HIGHER PROPORTION OF CLONAL CELLS, AND INFERIOR CLINICAL, OUTCOME, FOR PATIENTS WITH MONOSOMY-7 AS COMPARED WITH TRISOMY-8
Authors: BERNELL P STENKE L JACOBSSON B HAST R
Citation: P. Bernell et al., INTERPHASE CYTOGENETICS BY FISH MORPHOLOGY IN MYELODYSPLASTIC SYNDROMES - A HIGHER PROPORTION OF CLONAL CELLS, AND INFERIOR CLINICAL, OUTCOME, FOR PATIENTS WITH MONOSOMY-7 AS COMPARED WITH TRISOMY-8, Blood, 88(10), 1996, pp. 3333-3333
PATIENTS WITH DIFFUSE LARGE B-CELL NON-HODGKINS-LYMPHOMA FREQUENTLY DISPLAY TRISOMY-7 EVEN WHERE MORPHOLOGIC SIGNS OF THE LYMPHOMA ARE ABSENT
Authors: BERNELL P HEDLUND A HJALMAR V JACOBSSON B HAST R
Citation: P. Bernell et al., PATIENTS WITH DIFFUSE LARGE B-CELL NON-HODGKINS-LYMPHOMA FREQUENTLY DISPLAY TRISOMY-7 EVEN WHERE MORPHOLOGIC SIGNS OF THE LYMPHOMA ARE ABSENT, Blood, 88(10), 1996, pp. 3448-3448
A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/
Authors: LILIEMARK J BJORKHOLM M UDEN AM HAST R PAUL C SIMONSSON B TIDEFELT U JULIUSSON G HEDENUS M EVENSEN S TANGEN JM SJO M NESTHUS I HESTDAL K
Citation: J. Liliemark et al., A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/, Blood, 88(10), 1996, pp. 854-854
ENDOTOXEMIA AND INFLAMMATORY MEDIATORS IN FEBRILE PATIENTS WITH HEMATOLOGICAL DISEASE
Authors: GUNTHER G GARDLUND B HAST R KIMBY E NORDIN M WRETLIND B
Citation: G. Gunther et al., ENDOTOXEMIA AND INFLAMMATORY MEDIATORS IN FEBRILE PATIENTS WITH HEMATOLOGICAL DISEASE, Journal of internal medicine, 237(1), 1995, pp. 27-33
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
Authors: BJORKHOLM M LILIEMARK J GAHRTON G GRIMFORS G GRUBER A HAST R JULIUSSON G JARNMARK M KILLANDER A KIMBY E LERNER R LJUNGMAN P LONNQVIST B PALMBLAD J PAUL C PETTERSON C SIMONSSON B STALFELT AM STENKE L SUNDSTROM C TIDEFELT U UDEN AM OBERG G OST A
Citation: M. Bjorkholm et al., MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON, European journal of haematology, 55(1), 1995, pp. 19-23
PERIPHERAL-BLOOD NEUTROPHIL MORPHOLOGY REFLECTS BONE-MARROW DYSPLASIAIN MYELODYSPLASTIC SYNDROMES
Authors: WIDELL S HELLSTROMLINDBERG E KOCK Y LINDBERG M OST A HAST R
Citation: S. Widell et al., PERIPHERAL-BLOOD NEUTROPHIL MORPHOLOGY REFLECTS BONE-MARROW DYSPLASIAIN MYELODYSPLASTIC SYNDROMES, American journal of hematology, 49(2), 1995, pp. 115-120
RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INCOMBINATION WITH STANDARD INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA EVOLVING FROM MYELODYSPLASTIC SYNDROMES - A PILOT-STUDY
Authors: BERNELL P KIMBY E HAST R
Citation: P. Bernell et al., RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INCOMBINATION WITH STANDARD INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA EVOLVING FROM MYELODYSPLASTIC SYNDROMES - A PILOT-STUDY, Leukemia, 8(10), 1994, pp. 1631-1639
SEQUENTIAL TREATMENT WITH ERYTHROPOIETIN AND GM-CSF IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: BERNELL P WALLVIK J STENKE L HIPPE E GRUBER A GRIMFORS G LOFVENBERG E HAST R
Citation: P. Bernell et al., SEQUENTIAL TREATMENT WITH ERYTHROPOIETIN AND GM-CSF IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 84(10), 1994, pp. 10000317-10000317
ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: OSTERBORG A BJORKHOLM M BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GYLLENHAMMAR H HAST R JOHANSSON B JULIUSSON G JARNMARK M KIMBY E LERNER R LINDEMALM C LINDER O OHRLING M PAUL C SIMONSSON B SKARBERG KF SMEDMYR B STRANDER H SVEDMYR E TIDEFELT U UDEN AM WERNER B OSBY E MELLSTEDT H
Citation: A. Osterborg et al., ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY, Blood, 84(10), 1994, pp. 10000657-10000657
Risultati: 1-25 | 26-31